relcovaptan has been researched along with Disease Models, Animal in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 10 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Best, C; Brydges, NM; Drake, AJ; Hall, J; Lewis, C; Rule, L; Thomas, KL; Watkin, H | 1 |
| Cenksoy, C; Cenksoy, PO; Erdem, O; Gursoy, R; Sancak, B | 1 |
| Bowen, MT; McGregor, IS | 1 |
| Abidi, NH; Baumgarten, CM; Filippidis, AS; Henderson, SC; Liang, X; Marmarou, CR; Parveen, S; Taya, K; Young, HF | 1 |
| Krieg, SM; Plesnila, N; Sonanini, S; Trabold, R | 1 |
| Gu, H; Liu, ZW; Ma, XD; Song, JN; Zhang, BF; Zhao, JJ; Zhao, YH; Zhao, YL | 1 |
| Dehpour, AR; Doustimotlagh, AH; Javadi-Paydar, M; Javadian, N; Rahimi, N | 1 |
| Cragg, B; Ji, G; Neugebauer, V | 1 |
| Asaka, J; Iwata, K; Katagiri, A; Kubo, A; Shinoda, M; Suzuki, T; Takeda, M; Yeomans, DC | 1 |
| Gulsen, S; Marmarou, A; Marmarou, CR; Okuno, K; Prieto, R; Taya, K | 1 |
| Fazzina, G; Gulsen, S; Kleindienst, A; Marmarou, A; Marmarou, CR; Okuno, K; Ozisik, P; Taya, K | 1 |
| Dunbar, JG; Glisson, R; Kleindienst, A; Marmarou, A | 1 |
| Noor, R; Shuaib, A; Xu Wang, C; Yang, T | 1 |
| Ji, X; Kurahashi, K; Murakami, S; Nishihashi, T; Trandafir, CC; Wang, A | 1 |
| Abassi, ZA; Abu-Saleh, N; Azzam, ZS; Bishara, B; Hoffman, A; Karram, T; Nitecki, S; Rubinstein, I; Shiekh, H; Winaver, J | 1 |
| Dapzol, J; Girod, V; Grélot, L; Maffrand, JP; Serradeil-Le Gal, C | 1 |
16 other study(ies) available for relcovaptan and Disease Models, Animal
| Article | Year |
|---|---|
Childhood stress impairs social function through AVP-dependent mechanisms.
Topics: Adult; Adverse Childhood Experiences; Aged; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Behavior, Animal; Borderline Personality Disorder; Disease Models, Animal; Female; Humans; Indoles; Male; Middle Aged; Neurophysins; Paraventricular Hypothalamic Nucleus; Protein Precursors; Pyrrolidines; Rats; Sexual Maturation; Social Behavior; Stress, Psychological; Supraoptic Nucleus; Vasopressins; Young Adult | 2019 |
A potential novel strategy, inhibition of vasopressin-induced VEGF secretion by relcovaptan, for decreasing the incidence of ovarian hyperstimulation syndrome in the hyperstimulated rat model.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Ascitic Fluid; Chorionic Gonadotropin; Corpus Luteum; Disease Models, Animal; Female; Follicular Atresia; Gonadotropin-Releasing Hormone; Gonadotropins, Equine; Indoles; Organ Size; Ovarian Hyperstimulation Syndrome; Ovary; Ovulation Induction; Pyrrolidines; Rats; Rats, Wistar; Vascular Endothelial Growth Factor A; Vasopressins; Weight Gain | 2014 |
Oxytocin and vasopressin modulate the social response to threat: a preclinical study.
Topics: Aggression; Analysis of Variance; Animals; Cats; Disease Models, Animal; Drug Interactions; Hormone Antagonists; Indoles; Male; Odorants; Oxytocin; Pyrrolidines; Rats; Rats, Wistar; Stress, Psychological; Vasopressins | 2014 |
Selective vasopressin-1a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and GFAP, V1aR and AQP4 expression after focal traumatic brain injury.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 4; Astrocytes; Brain Edema; Brain Injuries; Disease Models, Animal; Gene Expression; Glial Fibrillary Acidic Protein; Immunohistochemistry; Indoles; Male; Microscopy, Confocal; Neuroprotective Agents; Pyrrolidines; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin | 2014 |
Effect of small molecule vasopressin V1a and V2 receptor antagonists on brain edema formation and secondary brain damage following traumatic brain injury in mice.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Brain Edema; Brain Injuries; Disease Models, Animal; Indoles; Male; Mice; Mice, Inbred C57BL; Morpholines; Pyrrolidines; Receptors, Vasopressin; Spiro Compounds | 2015 |
Rapidly increased vasopressin promotes acute platelet aggregation and early brain injury after experimental subarachnoid hemorrhage in a rat model.
Topics: Animals; Apoptosis; Brain; Disease Models, Animal; Disease Progression; Enzyme-Linked Immunosorbent Assay; Hormone Antagonists; Immunohistochemistry; Indoles; Male; Neuroprotective Agents; Platelet Aggregation; Pyrrolidines; Random Allocation; Rats, Sprague-Dawley; Subarachnoid Hemorrhage; Time Factors; Vasopressins | 2016 |
The modulatory effect of nitric oxide in pro- and anti-convulsive effects of vasopressin in PTZ-induced seizures threshold in mice.
Topics: Animals; Anticonvulsants; Antidiuretic Hormone Receptor Antagonists; Arginine; Arginine Vasopressin; Convulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanidines; Indoles; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pentylenetetrazole; Pyrrolidines; Receptors, Vasopressin; Seizures | 2016 |
Differential contributions of vasopressin V1A and oxytocin receptors in the amygdala to pain-related behaviors in rats.
Topics: Amygdala; Animals; Arthritis; Benzoxazines; Carrageenan; Disease Models, Animal; Hormone Antagonists; Indoles; Kaolin; Male; Maze Learning; Microdialysis; Pain; Piperidines; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Oxytocin; Receptors, Vasopressin; Reflex; Vocalization, Animal | 2016 |
Oxytocin alleviates orofacial mechanical hypersensitivity associated with infraorbital nerve injury through vasopressin-1A receptors of the rat trigeminal ganglia.
Topics: Animals; Cells, Cultured; Disease Models, Animal; Facial Pain; Hormone Antagonists; Hyperalgesia; Indoles; Male; Membrane Potentials; Neurons; Oxytocin; Pain Threshold; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Oxytocin; Receptors, Vasopressin; Trigeminal Ganglion; Vibrissae | 2017 |
Modulation of AQP4 expression by the selective V1a receptor antagonist, SR49059, decreases trauma-induced brain edema.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 4; Brain Edema; Brain Injuries; Disease Models, Animal; Functional Laterality; Indoles; Male; Pyrrolidines; Random Allocation; Rats; Rats, Sprague-Dawley; Up-Regulation | 2008 |
The modulation of aquaporin-4 by using PKC-activator (phorbol myristate acetate) and V1a receptor antagonist (SR49059) following middle cerebral artery occlusion/reperfusion in the rat.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 4; Brain Edema; Disease Models, Animal; Enzyme Activation; Indoles; Infarction, Middle Cerebral Artery; Male; Protein Kinase C; Pyrrolidines; Rats; Rats, Sprague-Dawley; Reperfusion; Tetradecanoylphorbol Acetate; Time Factors; Voltage-Dependent Anion Channels | 2008 |
The role of vasopressin V1A receptors in cytotoxic brain edema formation following brain injury.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 4; Brain Edema; Brain Injuries; Disease Models, Animal; Hormone Antagonists; Indoles; Infarction, Middle Cerebral Artery; Male; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin | 2013 |
Effects of nonpeptide V(1) vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Behavior, Animal; Brain Edema; Cerebral Infarction; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Hormone Antagonists; Indoles; Infarction, Middle Cerebral Artery; Intracranial Embolism; Male; Neuroprotective Agents; Pyrrolidines; Rats; Rats, Wistar; Recovery of Function; Stroke; Time Factors; Treatment Outcome | 2002 |
Participation of vasopressin in the development of cerebral vasospasm in a rat model of subarachnoid haemorrhage.
Topics: Animals; Arginine Vasopressin; Basilar Artery; Disease Models, Animal; Female; Indoles; Pyrans; Pyrrolidines; Quinolones; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2004 |
Effects of novel vasopressin receptor antagonists on renal function and cardiac hypertrophy in rats with experimental congestive heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Body Weight; Cardiomegaly; Disease Models, Animal; Diuresis; Drug Administration Schedule; Heart Failure; Indoles; Kidney Function Tests; Male; Morpholines; Organ Size; Osmolar Concentration; Pyrrolidines; Rats; Rats, Sprague-Dawley; Sodium; Spiro Compounds; Vasoconstriction | 2008 |
A nonpeptide vasopressin V(1a) receptor antagonist, SR 49059, does not prevent cisplatin-induced emesis in piglets.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Antiemetics; Antineoplastic Agents; Arginine Vasopressin; Cell Membrane; Cisplatin; Disease Models, Animal; Hormone Antagonists; Hypertension; Indoles; Liver; Pyrrolidines; Swine; Vomiting | 2001 |